Does age affect outcome with breast cancer?

Autor: B Jackson E; BC Cancer Vancouver Centre, Vancouver, BC, Canada; University of British Columbia, Canada. Electronic address: Emily.Jackson@bccancer.bc.ca., Gondara L; Breast Cancer Outcomes Unit, BC Cancer, Vancouver, BC, Canada., Speers C; Breast Cancer Outcomes Unit, BC Cancer, Vancouver, BC, Canada., Diocee R; Breast Cancer Outcomes Unit, BC Cancer, Vancouver, BC, Canada., M Nichol A; BC Cancer Vancouver Centre, Vancouver, BC, Canada; University of British Columbia, Canada., Lohrisch C; BC Cancer Vancouver Centre, Vancouver, BC, Canada; University of British Columbia, Canada., A Gelmon K; BC Cancer Vancouver Centre, Vancouver, BC, Canada; University of British Columbia, Canada.
Jazyk: angličtina
Zdroj: Breast (Edinburgh, Scotland) [Breast] 2023 Aug; Vol. 70, pp. 25-31. Date of Electronic Publication: 2023 Jun 02.
DOI: 10.1016/j.breast.2023.06.001
Abstrakt: Prior data about the influence of age at diagnosis of breast cancer on patient outcomes and survival has been conflicting. Using the Breast Cancer Outcomes Unit database at BC Cancer, this retrospective population-based study identified a cohort of 24,469 patients diagnosed with invasive breast cancer between 2005 and 2014. Median follow-up was 11.5 years. We analyzed clinical and pathological features at diagnosis and treatment specific variables compared across the following age cohorts: <35, 35-39, 40-49, 50-59, 60-69, 70-79, and 80 years of age and older. We assessed the impact of age on breast cancer specific survival (BCSS) and overall survival (OS) by age and subtype. There were distinct clinical-pathological and treatment pattern differences at both extremes of age at diagnosis. Patients <35 and 35-39 years old were more likely to present with higher risk features, HER2 positive or triple-negative biomarkers, and more advanced TNM stage at diagnosis. They were more likely to undergo treatment with mastectomy, axillary lymph node dissection, radiotherapy and chemotherapy. Conversely, patients ≥80 years old were generally more likely to have hormone-sensitive HER2-negative disease, and lower TNM stage at diagnosis. They were less likely to undergo surgery or be treated with radiotherapy and chemotherapy. Both younger and elderly age at breast cancer diagnosis were independent risk factors for poorer prognosis after controlling for subtype, LVI, stage, and treatment factors. This work will help clinicians to more accurately estimate patient outcomes, patterns of relapse, and provide evidence-based treatment recommendations.
Competing Interests: Declaration of competing interest The authors have declared no conflicts of interest.
(Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: